Article from Kings College of London News Centre By Adrian Hayday, Professor of Immunobiology "More than half of cancer patients receiving a single dose of the Pfizer COVID-19 vaccine have been left with little protection against the virus. Data from the world’s...
Delaying second vaccine dose leaves cancer patients vulnerable to virus
https://www.kcl.ac.uk/news/delaying-second-vaccine-dose-cancer-patients-vulnerable-virusread more